Citizens Financial Group Inc. RI Takes Position in MetLife, Inc. $MET

Citizens Financial Group Inc. RI purchased a new stake in shares of MetLife, Inc. (NYSE:MET) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 18,753 shares of the financial services provider’s stock, valued at approximately $1,587,000.

Several other hedge funds and other institutional investors have also bought and sold shares of MET. Strs Ohio boosted its holdings in MetLife by 16.6% in the 4th quarter. Strs Ohio now owns 326,091 shares of the financial services provider’s stock worth $25,742,000 after buying an additional 46,469 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH lifted its position in shares of MetLife by 2.1% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 714,193 shares of the financial services provider’s stock worth $56,712,000 after acquiring an additional 14,515 shares in the last quarter. PFA Pension Forsikringsaktieselskab purchased a new stake in shares of MetLife during the fourth quarter worth $81,494,000. Evergreen Capital Management LLC boosted its holdings in shares of MetLife by 195.8% in the fourth quarter. Evergreen Capital Management LLC now owns 33,260 shares of the financial services provider’s stock worth $2,626,000 after acquiring an additional 22,016 shares during the period. Finally, Principal Financial Group Inc. grew its position in shares of MetLife by 2.2% in the fourth quarter. Principal Financial Group Inc. now owns 622,789 shares of the financial services provider’s stock valued at $49,163,000 after purchasing an additional 13,657 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. TD Cowen upped their price target on shares of MetLife from $87.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd. Piper Sandler boosted their target price on MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Mizuho upped their target price on MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Barclays raised their price target on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, Morgan Stanley lifted their price target on MetLife from $93.00 to $103.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and an average price target of $101.07.

More MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

MetLife Trading Up 0.2%

NYSE:MET opened at $96.83 on Wednesday. The company has a fifty day moving average of $92.00 and a 200 day moving average of $81.86. MetLife, Inc. has a 52 week low of $67.33 and a 52 week high of $100.93. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $62.31 billion, a P/E ratio of 18.55, a P/E/G ratio of 0.75 and a beta of 0.78.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter last year, the firm earned $2.02 EPS. The company’s revenue was up 10.5% on a year-over-year basis. On average, research analysts predict that MetLife, Inc. will post 9.7 earnings per share for the current year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be paid a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 annualized dividend and a dividend yield of 2.4%. MetLife’s dividend payout ratio (DPR) is presently 45.40%.

MetLife announced that its board has authorized a stock repurchase program on Wednesday, August 5th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.